RB
Raghuveer Beti
About Raghuveer Beti
Raghuveer Beti has 22 years in corporate governance. Holds Managing Director and Director roles. Currently with 3 companies, including Bethi Medikamente Private Limited and Pegasus Farmaco (India) Private Limited. Formerly with 1 company, such as Glory Pharmachem India Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bethi Medikamente Private Limited
U24100TG2012PTC078487
|
Managing Director | 10 Jan 2012 | 2012 | Active |
Pegasus Farmaco (India) Private Limited
U24230TG1995PTC022036
|
Managing Director | 12 Apr 2004 | 1995 | Active |
Livnaturl Wellness Private Limited
U24299TG2019PTC129945
|
Director | 22 Jan 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Glory Pharmachem India Private Limited
U24232TG2007PTC053462
|
Director | 03 Feb 2017 | 2007 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raghuveer Beti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raghuveer Beti
Raghuveer Beti has 22 years in corporate governance. Holds Managing Director and Director roles. Currently with 3 companies, including Bethi Medikamente Private Limited and Pegasus Farmaco (India) Private Limited. Formerly with 1 company, such as Glory Pharmachem India Private Limited. Engaged in General Business. Contributes to corporate operations.
Raghuveer Beti is associated with 3 companies as Managing Director and Director.
Raghuveer Beti has expertise in General Business.
Raghuveer Beti has 22 years in corporate governance.